BioHarvest Sciences Share Holder Equity 2020-2024 | BHST
BioHarvest Sciences share holder equity from 2020 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
BioHarvest Sciences Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$-15 |
| 2022 |
$-6 |
| 2021 |
$3 |
| 2020 |
$-2 |
| 2019 |
$-27 |
| 2019 |
$4 |
| 2018 |
$4 |
BioHarvest Sciences Quarterly Share Holder Equity
(Millions of US $) |
| 2024-06-30 |
$7 |
| 2024-03-31 |
$-3 |
| 2023-12-31 |
$-15 |
| 2023-09-30 |
$-8 |
| 2023-06-30 |
$-6 |
| 2023-03-31 |
$-5 |
| 2022-12-31 |
$-6 |
| 2022-09-30 |
$-4 |
| 2022-06-30 |
$-1 |
| 2022-03-31 |
$1 |
| 2021-12-31 |
$3 |
| 2021-09-30 |
$4 |
| 2021-06-30 |
$0 |
| 2021-03-31 |
$-3 |
| 2020-12-31 |
$-2 |
| 2020-09-30 |
$-0 |
| 2020-06-30 |
$-2 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
|
| 2019-09-30 |
$0 |
| 2019-06-30 |
$0 |
| 2019-03-31 |
$4 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
|
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|
